Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10001081HBVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS10024275HBVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS10028746HBVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS10051403HBVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS30007809HIVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS30086751HIVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS30051588HIVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS30051589HIVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS30051590HIVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TVIS20002038HPVENSG00000184611.14protein_codingKCNH7NoNo90134Q9NS40
TCGA Plot Options
Drug Information
GeneKCNH7
DrugBank IDDB01162
Drug NameTerazosin
Target IDBE0000699
UniProt IDQ9NS40
Regulation Typeinhibitor
PubMed IDs15098086
CitationsThomas D, Wimmer AB, Wu K, Hammerling BC, Ficker EK, Kuryshev YA, Kiehn J, Katus HA, Schoels W, Karle CA: Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Naunyn Schmiedebergs Arch Pharmacol. 2004 May;369(5):462-72. Epub 2004 Apr 20.
GroupsApproved
Direct ClassificationN-arylpiperazines
SMILESCOC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1
Pathways
PharmGKBPA451612
ChEMBLCHEMBL611